6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
Evidence-based guide to liraglutide dosing considerations for Black and African ancestry patients, including pharmacogenomic factors, clinical trial subgroup data, and titration protocols.
A clinically detailed review of liraglutide dosing in East Asian patients, covering pharmacokinetics, ethnicity-stratified trial data, BMI thresholds, and pharmacogenomic considerations including CYP2C19 and CYP2D6 polymorphisms.
Evidence-based review of liraglutide response differences in Black and African ancestry populations, including ethnicity-stratified trial data, pharmacogenomic factors, and clinical dosing guidance.
Evidence-based review of how liraglutide safety, pharmacogenomics, and dosing considerations differ for Hispanic and Latino populations, with ethnicity-stratified trial data and clinical guidance.
A guide to liraglutide dosing considerations for South Asian patients, covering ethnicity-adjusted BMI thresholds, cardiovascular risk context, pharmacokinetic reasoning, and where the evidence runs out.
South Asian patients face higher cardiovascular risk at lower BMI, earlier diabetes onset, and distinct pharmacogenomic variation. This clinical review covers liraglutide efficacy, safety signals, and dosing considerations specific to South Asian populations, with citations to ethnicity-stratified trial subgroups and guideline recommendations.